Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

10694.  Apaydin R, Bahadir S, Kakklikkaya N, Bilen N, Bayramgurler D. Possible role of Mycobacterium tuberculosis complex in Melkersson-Rosenthal syndrome demonstrated with Gen-Probe amplified Mycobacterium tuberculosis direct test. Australas J Dermatol. 2004 May;45(2):94-9.

10695.  Arora VK, Lonnroth K, Sarin R. Improved case detection of tuberculosis through a public-private partnership. Indian J Chest Dis Allied Sci. 2004 Apr-Jun;46(2):133-6.

10696.  Balganesh TS, Balasubramanian V, Anand Kumar S. Drug discovery for tuberculosis: Bottlenecks and path forward. Curr Sci 2004; 86(1): 167-76.

10697.  Basu J. Mycobacteria within its intracellular niche: survival of the pathogen or its host. Curr Sci 2004; 86(1): 103-10.

10698.  Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS, Fabian K, Ullmann AJ, Wulffraat N, Ljungman P, Alessandrino EP, Pretnar J, Gmur J, Varela R, Vitek A, Sica S, Rovira M; European Blood and Marrow Transplant Group Infectious Diseases Working Party. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis. 2004 May 1;38(9):1229-36.

10699.  Drobniewski F, Balabanova Y, Coker R. Clinical features, diagnosis, and management of multiple drug-resistant tuberculosis since 2002. Curr Opin Pulm Med. 2004 May;10(3):211-7. Review.

10700.  Gupta S, Kumar S, Harinath BC. Mycobacterium tuberculosis excretory secretory (ES) protein antigens of interest in diagnosis, prognosis and prediction of disease development. J. MGIMS, 2004 Sept.; 9(ii): 16-21. Review.  

10701.  Hill PC, Brookes RH, Fox A, Fielding K, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Otu JK, Corrah T, Adegbola RA, McAdam KP. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis. 2004 Apr 1;38(7):966-73.

10702.  Immmanuel C, Gurumurthy P, Ramachandran G, Venkatesan P, Chandrasekaran V, Prabhakar R. Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs. Indian J med Res 2003; 118(Sep): 109-14.

10703.  Kim HC, Goo JM, Lee HJ, Park SH, Park CM, Kim TJ, Im JG. Multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in human immunodeficiency virus-negative patients: computed tomography features. J Comput Assist Tomogr. 2004 May-Jun;28(3):366-71.

10704.  Kumar N, Jain S, Murthy NS. Utility of repeat fine needle aspiration in acute suppurative lesions. Follow-up of 263 cases. Acta Cytol. 2004 May-Jun;48(3):337-40.

10705.  Liu XQ, Dosanjh D, Varia H, Ewer K, Cockle P, Pasvol G, Lalvani A. Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun. 2004 May;72(5):2574-81.

10706.  Mahapatro S; Choudhury S; Tripathy S; Khan M.A; Rao ES. Tuberculous thyroid abscess. Antiseptic. 2004 Feb; 101(2): 46-7.

10707.  Noordhoek GT, Mulder S, Wallace P, van Loon AM. Multicentre quality control study for detection of Mycobacterium tuberculosis in clinical samples by nucleic amplification methods. Clin Microbiol Infect. 2004 Apr;10(4):295-301.

10708.  Prasad R, Saini JK, Gupta R, Kannaujia RK, Sarin S, Suryakant, Kulshreshth R, Nag VL, Tripathi AK. A comparative study of clinico-radiological spectrum of tuberculosis among HIV seropositive and HIV seronegative patients. Indian J Chest Dis Allied Sci. 2004 Apr-Jun;46(2):99-103.

10709.  Ramakrishnan L. Using mycobacterium marinum and its hosts to study tuberculosis. Curr Sci 2004; 86(1): 82-92.

10710.  Selvaraj P. Host genetics and tuberculosis susceptibility. Curr Sci 2004; 86(1):115-21.

10711.  Sharma SK; Mohan A. Co-infection of human immunodeficiency virus (HIV) and tuberculosis: Indian perspective Indian Journal of Tuberculosis. 2004 Jan; 51(1): 5-16

10712.  Sougakoff W, Rodrigue M, Truffot-Pernot C, Renard M, Durin N, Szpytma M, Vachon R, Troesch A, Jarlier V. Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect. 2004 Apr;10(4):289-94.

10713.  Thorson A, Hoa NP, Long NH, Allebeck P, Diwan VK. Do women with tuberculosis have a lower likelihood of getting diagnosed? Prevalence and case detection of sputum smear positive pulmonary TB, a population-based study from Vietnam. J Clin Epidemiol. 2004 Apr;57(4):398-402.

10714.  van Deutekom H, Hoijng SP, de Haas PE, Langendam MW, Horsman A, van Soolingen D, Coutinho RA. Clustered tuberculosis cases: do they represent recent transmission and can they be detected earlier? Am J Respir Crit Care Med. 2004 Apr 1;169(7):806-10.

10715.  Visca P, De Mori P, Festa A, Montrone ML, Amicosante M, Pucillo LP. Evaluation of the BDProbeTec strand displacement amplification assay in comparison with the AMTD II direct test for rapid diagnosis of tuberculosis. Clin Microbiol Infect. 2004 Apr;10(4):332-4.

10716.  Vrioni G, Levidiotou S, Matsiota-Bernard P, Marinis E. Molecular characterization of Mycobacterium tuberculosis isolates presenting various drug susceptibility from Greece using three DNA typing methods. J Infect. 2004 Apr;48(3):253-62.



10717.  Awomoyi AA, Nejentsev S, Richardson A, Hull J, Koch O, Podinovskaia M, Todd JA, McAdam KP, Blackwell JM, Kwiatkowski D, Newport MJ. No association between interferon-gamma receptor-1 gene polymorphism and pulmonary tuberculosis in a Gambian population sample. Thorax. 2004 Apr;59(4):291-4.

10718.  Bates I, Fenton C, Gruber J, Lalloo D, Lara AM, Squire SB, Theobald S, Thomson R, Tolhurst R. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part II: Determinants operating at environmental and institutional level. Lancet Infect Dis. 2004 Jun;4(6):368-75. Review.

10719.  Bates I, Fenton C, Gruber J, Lalloo D, Medina Lara A, Squire SB, Theobald S, Thomson R, Tolhurst R. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis. 2004 May;4(5):267-77. Review.

10720.  Bonecini-Almeida MG, Ho JL, Boechat N, Huard RC, Chitale S, Doo H, Geng J, Rego L, Lazzarini LC, Kritski AL, Johnson WD Jr, McCaffrey TA, Silva JR. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun. 2004 May;72(5):2628-34.

10721.  Curto M, Reali C, Palmieri G, Scintu F, Schivo ML, Sogos V, Marcialis MA, Ennas MG, Schwarz H, Pozzi G, Gremo F. Inhibition of cytokines expression in human microglia infected by virulent and non-virulent mycobacteria. Neurochem Int. 2004 May;44(6):381-92.

10722.  Dao DN, Kremer L, Guerardel Y, Molano A, Jacobs WR Jr, Porcelli SA, Briken V.  Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect Immun. 2004 Apr;72(4):2067-74.

10723.  Davies PD. Molecular epidemiology unmasks the tubercle bacillus: new techniques reveal new aspects of virulence. Thorax. 2004 Apr;59(4):273-4.

10724.  Hussey G, Hawkridge T, Eley B, Nuttall J, Kibel M, Geiter L, Barker L, Behr M, Demers AM. Adverse effects of bacille Calmette-Guerin vaccination in HIV-positive infants. Clin Infect Dis. 2004 May 1;38(9):1333-4.

10725.  Marino S, Kirschner DE. The human immune response to Mycobacterium tuberculosis in lung and lymph node. J Theor Biol. 2004 Apr 21;227(4):463-86.

10726.  McGarvey JA, Wagner D, Bermudez LE. Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria. Clin Exp Immunol. 2004 Jun;136(3):490-500.

10727.  Thakurdas SM, Hasan Z, Hussain R. IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-alpha) secreted by mycobacterial antigen-stimulated adherent cells. Clin Exp Immunol. 2004 May;136(2):320-7.

10728.  Tibayrenc M. A molecular biology approach to tuberculosis. Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4721-2.

10729.  Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci. 2004 May 1;9:1136-56. Review.



10730.  Dye C. A booster for tuberculosis vaccines. JAMA. 2004 May 5;291(17):2127-8.


10731.  Garca-Doval I. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection. J Am Acad Dermatol. 2004 May;50(5):801; author reply 801-2.

10732.  Maher D, Blanc L, Raviglione M. WHO policies for tuberculosis control. Lancet. 2004 Jun 5;363(9424):1911.

10733.  Stanford J, Stanford C, Grange J. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. Front Biosci. 2004 May 1;9:1701-19. Review.